B. Metzler Seel. Sohn & Co. Ag Revolution Medicines, Inc. Call Options Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.53 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVMD
# of Institutions
298Shares Held
181MCall Options Held
476KPut Options Held
864K-
Vanguard Group Inc Valley Forge, PA17.1MShares$695 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$545 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$539 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$440 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$386 Million0.22% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.57B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...